Published in J Virol on October 02, 2013
Viral Source-Independent High Susceptibility of Dendritic Cells to Human T-Cell Leukemia Virus Type 1 Infection Compared to That of T Lymphocytes. J Virol (2015) 0.83
ADAR1 enhances HTLV-1 and HTLV-2 replication through inhibition of PKR activity. Retrovirology (2014) 0.78
HIV-1 Tat protein enhances the intracellular growth of Leishmania amazonensis via the ds-RNA induced protein PKR. Sci Rep (2015) 0.78
Involvement of double-stranded RNA-dependent protein kinase and antisense viral RNA in the constitutive NFκB activation in adult T-cell leukemia/lymphoma cells. Leukemia (2014) 0.78
Dendritic cell maturation, but not type I interferon exposure, restricts infection by HTLV-1, and viral transmission to T-cells. PLoS Pathog (2017) 0.77
Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet (1985) 13.47
Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci (1957) 13.46
A diverse range of gene products are effectors of the type I interferon antiviral response. Nature (2011) 12.86
HTLV-I associated myelopathy, a new clinical entity. Lancet (1986) 10.49
Interferon-inducible antiviral effectors. Nat Rev Immunol (2008) 9.68
Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin. J Virol (2008) 4.72
Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: an open reading frame for the protease gene. Proc Natl Acad Sci U S A (1985) 4.28
Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N Engl J Med (1995) 3.26
Epidemiological Aspects and World Distribution of HTLV-1 Infection. Front Microbiol (2012) 3.03
Molecular characterization of genome of a novel human T-cell leukaemia virus. Nature (1983) 2.36
Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation. Cell Host Microbe (2009) 2.33
Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes. J Clin Oncol (2010) 2.27
Construction and characterization of infectious human T-cell leukemia virus type 1 molecular clones. Virology (1994) 2.14
Monoclonal antibodies to an interferon-induced Mr 68,000 protein and their use for the detection of double-stranded RNA-dependent protein kinase in human cells. Proc Natl Acad Sci U S A (1985) 2.09
Biofilm-like extracellular viral assemblies mediate HTLV-1 cell-to-cell transmission at virological synapses. Nat Med (2009) 1.92
Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infection. Blood (2008) 1.88
Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood (2000) 1.87
Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2. Oncogene (2005) 1.73
Examining human T-lymphotropic virus type 1 infection and replication by cell-free infection with recombinant virus vectors. J Virol (2001) 1.73
Characterization of the alpha interferon-induced postentry block to HIV-1 infection in primary human macrophages and T cells. J Virol (2010) 1.69
Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa. N Engl J Med (1995) 1.67
The interferons and their receptors--distribution and regulation. Immunol Cell Biol (2012) 1.41
A 10-amino acid domain within human T-cell leukemia virus type 1 and type 2 tax protein sequences is responsible for their divergent subcellular distribution. J Biol Chem (2004) 1.37
Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence. Blood (2006) 1.33
Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial. Neurology (1996) 1.32
HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. The REDS investigators. Neurology (1997) 1.30
Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/ tropical spastic paraparesis. J Neurovirol (1996) 1.29
The yin and yang of viruses and interferons. Trends Immunol (2012) 1.25
Hepatitis C virus controls interferon production through PKR activation. PLoS One (2010) 1.21
Arsenic trioxide and interferon-alpha synergize to induce cell cycle arrest and apoptosis in human T-cell lymphotropic virus type I-transformed cells. Blood (1999) 1.18
Depletion and impaired interferon-alpha-producing capacity of blood plasmacytoid dendritic cells in human T-cell leukaemia virus type I-infected individuals. Br J Haematol (2004) 1.18
AZT inhibits the transmission of human T cell leukaemia/lymphoma virus type I to adult peripheral blood mononuclear cells in vitro. J Gen Virol (1997) 1.13
Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis. Viruses (2010) 1.13
Protein kinase R is responsible for the phosphorylation of eIF2alpha in rotavirus infection. J Virol (2010) 1.06
HTLV-1 gene expression by defective proviruses in an infected T-cell line. Virology (1993) 1.05
Human T cell leukemia virus type 1 Tax inhibits innate antiviral signaling via NF-kappaB-dependent induction of SOCS1. J Virol (2011) 1.05
Alpha interferon inhibits human T-cell leukemia virus type 1 assembly by preventing Gag interaction with rafts. J Virol (2003) 1.03
Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy. PLoS Pathog (2012) 1.03
Pathways of cell-cell transmission of HTLV-1. Front Microbiol (2012) 1.02
Human T cell leukemia virus type 2 tax-mediated NF-κB activation involves a mechanism independent of Tax conjugation to ubiquitin and SUMO. J Virol (2012) 1.01
HTLV-1 evades type I interferon antiviral signaling by inducing the suppressor of cytokine signaling 1 (SOCS1). PLoS Pathog (2010) 1.01
A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia/lymphoma. Hematol J (2002) 0.99
Long-term, high dose interferon-alpha treatment in HTLV-I-associated myelopathy/tropical spastic paraparesis: a combined clinical, virological and immunological study. J Neurol Sci (1997) 0.99
Free HTLV-1 induces TLR7-dependent innate immune response and TRAIL relocalization in killer plasmacytoid dendritic cells. Blood (2009) 0.99
Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphoma. PLoS One (2009) 0.99
Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis. J Infect Dis (2003) 0.97
HTLV-1: persistence and pathogenesis. Virology (2013) 0.97
Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patients. Br J Haematol (2001) 0.97
The combination of zidovudine and interferon alpha-2B in the treatment of adult T-cell leukemia/lymphoma. Leuk Lymphoma (2001) 0.96
Arsenic trioxide induces apoptosis in human T-cell leukemia virus type 1- and type 2-infected cells by a caspase-3-dependent mechanism involving Bcl-2 cleavage. Blood (2001) 0.96
Human T-cell leukemia virus type 1 Tax modulates interferon-alpha signal transduction through competitive usage of the coactivator CBP/p300. Virology (2008) 0.96
Evidence against a direct cytotoxic effect of alpha interferon and zidovudine in HTLV-I associated adult T cell leukemia/lymphoma. Leukemia (2000) 0.96
Lethal Nipah virus infection induces rapid overexpression of CXCL10. PLoS One (2012) 0.95
Comparison of the Genetic Organization, Expression Strategies and Oncogenic Potential of HTLV-1 and HTLV-2. Leuk Res Treatment (2011) 0.94
Interferon-α (IFN-α) suppresses HTLV-1 gene expression and cell cycling, while IFN-α combined with zidovudine induces p53 signaling and apoptosis in HTLV-1-infected cells. Retrovirology (2013) 0.93
A chimeric human T-cell lymphotropic virus type 1 with the envelope glycoprotein of Moloney murine leukemia virus is infectious for murine cells. J Virol (2002) 0.92
Stromal cell-mediated suppression of human T-cell leukemia virus type 1 expression in vitro and in vivo by type I interferon. J Virol (2009) 0.91
Systemic interferon-alpha in the treatment of HTLV-I-associated myelopathy. Acta Neurol Scand (1992) 0.90
Human T-cell leukemia virus type 1 blunts signaling by interferon alpha. Virology (2008) 0.89
Molecular aspects of HTLV-1 entry: functional domains of the HTLV-1 surface subunit (SU) and their relationships to the entry receptors. Viruses (2011) 0.88
HTLV-1 and innate immunity. Viruses (2011) 0.85
A cell-permeable peptide inhibits activation of PKR and enhances cell proliferation. Peptides (2000) 0.85
HTLV-I-infected T cells evade the antiproliferative action of IFN-beta. Virology (1999) 0.85
The roles of acquired and innate immunity in human T-cell leukemia virus type 1-mediated diseases. Front Microbiol (2012) 0.83
The third nation-wide study on adult T-cell leukemia/lymphoma (ATL) in Japan: characteristic patterns of HLA antigen and HTLV-I infection in ATL patients and their relatives. The T- and B-cell Malignancy Study Group. Int J Cancer (1988) 0.82
Cell-cell transmission allows human T-lymphotropic virus 1 to circumvent tetherin restriction. Virology (2012) 0.80
Safety and efficacy of interferon-alpha in 167 patients with human T-cell lymphotropic virus type 1-associated myelopathy. J Neurovirol (2007) 0.78
Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol (2008) 2.67
Bioluminescence imaging of myeloperoxidase activity in vivo. Nat Med (2009) 2.43
Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma. Blood (2009) 2.07
Discovery of a new human T-cell lymphotropic virus (HTLV-3) in Central Africa. Retrovirology (2005) 1.70
Structural and functional basis for ADP-ribose and poly(ADP-ribose) binding by viral macro domains. J Virol (2006) 1.70
Comparative mechanistic studies of de novo RNA synthesis by flavivirus RNA-dependent RNA polymerases. Virology (2006) 1.61
The severe acute respiratory syndrome-coronavirus replicative protein nsp9 is a single-stranded RNA-binding subunit unique in the RNA virus world. Proc Natl Acad Sci U S A (2004) 1.61
Retrovirus infection strongly enhances scrapie infectivity release in cell culture. EMBO J (2006) 1.53
Outcome of patients with relapsed/refractory acquired immune deficiency syndrome-related lymphoma diagnosed 1999-2008 and treated with curative intent in the AIDS Malignancy Consortium. Leuk Lymphoma (2012) 1.48
Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Retrovirology (2008) 1.45
The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas. Proc Natl Acad Sci U S A (2006) 1.39
Human T-cell lymphotropic virus type 1 open reading frame II-encoded p30II is required for in vivo replication: evidence of in vivo reversion. J Virol (2004) 1.37
A 10-amino acid domain within human T-cell leukemia virus type 1 and type 2 tax protein sequences is responsible for their divergent subcellular distribution. J Biol Chem (2004) 1.37
Pharmacokinetics and metabolism of ligustilide, a major bioactive component in Rhizoma Chuanxiong, in the rat. Drug Metab Dispos (2007) 1.35
Tax ubiquitylation and sumoylation control critical cytoplasmic and nuclear steps of NF-kappaB activation. Blood (2006) 1.33
The crystal structures of Chikungunya and Venezuelan equine encephalitis virus nsP3 macro domains define a conserved adenosine binding pocket. J Virol (2009) 1.32
Biological evaluation of substituted quinolines. Bioorg Med Chem Lett (2004) 1.30
Induction of the Galpha(q) signaling cascade by the human immunodeficiency virus envelope is required for virus entry. J Virol (2008) 1.25
Foxp3 represses retroviral transcription by targeting both NF-kappaB and CREB pathways. PLoS Pathog (2006) 1.24
Substituted quinolines induce inhibition of proliferation of HTLV-1 infected cells. Bioorg Med Chem Lett (2003) 1.22
HTLV-3/4 and simian foamy retroviruses in humans: discovery, epidemiology, cross-species transmission and molecular virology. Virology (2013) 1.21
The HTLV-I Tax oncoprotein targets the retinoblastoma protein for proteasomal degradation. Oncogene (2005) 1.18
Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study. J Clin Oncol (2002) 1.16
Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation. Oncogene (2005) 1.15
Transcription profile of cells infected with human T-cell leukemia virus type I compared with activated lymphocytes. Cancer Res (2002) 1.15
Role of Abl kinase and the Wave2 signaling complex in HIV-1 entry at a post-hemifusion step. PLoS Pathog (2010) 1.14
Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients. Blood (2013) 1.13
Human T-cell lymphotropic virus type 3: complete nucleotide sequence and characterization of the human tax3 protein. J Virol (2006) 1.11
HTLV-1 Tax transgenic mice develop spontaneous osteolytic bone metastases prevented by osteoclast inhibition. Blood (2005) 1.09
Effects of the proteasome inhibitor PS-341 on tumor growth in HTLV-1 Tax transgenic mice and Tax tumor transplants. Blood (2004) 1.09
NRP/Optineurin Cooperates with TAX1BP1 to potentiate the activation of NF-kappaB by human T-lymphotropic virus type 1 tax protein. PLoS Pathog (2009) 1.08
Hsp40 facilitates nuclear import of the human immunodeficiency virus type 2 Vpx-mediated preintegration complex. J Virol (2007) 1.08
Identification of the nuclear localization signal of human immunodeficiency virus type 2 Vpx. Virology (2003) 1.07
IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia/lymphoma. Blood (2007) 1.06
Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors. Blood (2010) 1.05
New strain of human T lymphotropic virus (HTLV) type 3 in a Pygmy from Cameroon with peculiar HTLV serologic results. J Infect Dis (2009) 1.05
Post-formulation peptide drug loading of nanostructures for metered control of NF-κB signaling. Biomaterials (2011) 1.04
HTLV gene regulation: because size matters, transcription is not enough. Future Microbiol (2009) 1.04
Alpha interferon inhibits human T-cell leukemia virus type 1 assembly by preventing Gag interaction with rafts. J Virol (2003) 1.03
Human T-lymphotropic virus type-1 p30 alters cell cycle G2 regulation of T lymphocytes to enhance cell survival. Retrovirology (2007) 1.02
Analysis of HIV-2 Vpx by modeling and insertional mutagenesis. Virology (2006) 1.02
Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivo. J Virol (2006) 1.02
Cytolytic nanoparticles attenuate HIV-1 infectivity. Antivir Ther (2012) 1.02
Human T cell leukemia virus type 2 tax-mediated NF-κB activation involves a mechanism independent of Tax conjugation to ubiquitin and SUMO. J Virol (2012) 1.01
Low nuclear body formation and tax SUMOylation do not prevent NF-kappaB promoter activation. Retrovirology (2012) 1.00
Enhanced tumorigenesis in HTLV-1 tax-transgenic mice deficient in interferon-gamma. Blood (2004) 1.00
Presence of a functional but dispensable nuclear export signal in the HTLV-2 Tax protein. Retrovirology (2005) 0.99
Multiple retroviral infection by HTLV type 1, 2, 3 and simian foamy virus in a family of Pygmies from Cameroon. Virology (2010) 0.97
Integrase inhibitors effective against human T-cell leukemia virus type 1. Antimicrob Agents Chemother (2011) 0.97
Imaging spontaneous tumorigenesis: inflammation precedes development of peripheral NK tumors. Blood (2008) 0.95
Mechanisms of nanoparticle-mediated siRNA transfection by melittin-derived peptides. ACS Nano (2013) 0.95
Acetylation of the human T-cell leukemia virus type 1 Tax oncoprotein by p300 promotes activation of the NF-kappaB pathway. Virology (2009) 0.94
HTLV-2B strains, similar to those found in several Amerindian tribes, are endemic in central African Bakola Pygmies. J Infect Dis (2011) 0.94
Role of human immunodeficiency virus type 1 matrix phosphorylation in an early postentry step of virus replication. J Virol (2004) 0.94
Characterization of replication defects induced by mutations in the basic domain and C-terminus of HIV-1 matrix. Virology (2007) 0.94
Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047. J Clin Oncol (2012) 0.94
The multifaceted oncoprotein Tax: subcellular localization, posttranslational modifications, and NF-κB activation. Adv Cancer Res (2012) 0.94
Vpx is critical for SIVmne infection of pigtail macaques. Retrovirology (2012) 0.93
The ARF tumor suppressor regulates bone remodeling and osteosarcoma development in mice. PLoS One (2010) 0.93
T-cell activation promotes tumorigenesis in inflammation-associated cancer. Retrovirology (2009) 0.93
Brucella β 1,2 cyclic glucan is an activator of human and mouse dendritic cells. PLoS Pathog (2012) 0.92
The modeled structure of the RNA dependent RNA polymerase of GBV-C virus suggests a role for motif E in Flaviviridae RNA polymerases. BMC Bioinformatics (2005) 0.92
Molecular determinants of human T-lymphotropic virus type 1 transmission and spread. Viruses (2011) 0.92
Histone acetyltransferase (HAT) activity of p300 modulates human T lymphotropic virus type 1 p30II-mediated repression of LTR transcriptional activity. Virology (2006) 0.92
HTLV-2 APH-2 expression is correlated with proviral load but APH-2 does not promote lymphocytosis. J Infect Dis (2011) 0.91
Construction and characterization of a full-length infectious simian T-cell lymphotropic virus type 3 molecular clone. J Virol (2007) 0.90
Cholesterol dependence of HTLV-I infection. AIDS Res Hum Retroviruses (2005) 0.90
Centrosome and retroviruses: the dangerous liaisons. Retrovirology (2007) 0.90
Human T-cell leukemia virus type 1 blunts signaling by interferon alpha. Virology (2008) 0.89
Functional analysis of the relationship between Vpx and the restriction factor SAMHD1. J Biol Chem (2012) 0.89
Engraftment and tumorigenesis of HTLV-1 transformed T cell lines in SCID/bg and NOD/SCID mice. Leuk Res (2002) 0.89
Construction and characterization of a human T-cell lymphotropic virus type 3 infectious molecular clone. J Virol (2008) 0.88
Inhibition of HTLV-1 transcription by cyclin dependent kinase inhibitors. Mol Cell Biochem (2002) 0.88
Mutation of critical serine residues in HIV-1 matrix result in an envelope incorporation defect which can be rescued by truncation of the gp41 cytoplasmic tail. Virology (2008) 0.88
Utilization of the CBP but not the p300 co-activator by human T-lymphotropic virus type-2 Tax for p53 inhibition. Oncogene (2004) 0.88
Identification of allosteric inhibitors blocking the hepatitis C virus polymerase NS5B in the RNA synthesis initiation step. Antiviral Res (2009) 0.87
Conference highlights of the 15th International Conference on Human Retrovirology: HTLV and related retroviruses, 4-8 June 2011, Leuven, Gembloux, Belgium. Retrovirology (2011) 0.87
Human prion protein binds Argonaute and promotes accumulation of microRNA effector complexes. Nat Struct Mol Biol (2012) 0.87
Preexisting infection with human T-cell lymphotropic virus type 2 neither exacerbates nor attenuates simian immunodeficiency virus SIVmac251 infection in macaques. J Virol (2010) 0.87
Molecular and clinical assessment in the treatment of AIDS Kaposi sarcoma with valproic Acid. Clin Infect Dis (2009) 0.87
Wip1 and p53 contribute to HTLV-1 Tax-induced tumorigenesis. Retrovirology (2012) 0.87
A novel, highly selective inhibitor of pestivirus replication that targets the viral RNA-dependent RNA polymerase. J Virol (2006) 0.86
Tax protein-induced expression of antiapoptotic Bfl-1 protein contributes to survival of human T-cell leukemia virus type 1 (HTLV-1)-infected T-cells. J Biol Chem (2012) 0.86
Anti-Vpr activity of a yeast chaperone protein. J Virol (2004) 0.86
Hepatitis viruses and hepatocellular carcinoma in HIV-infected patients. Curr Opin Oncol (2002) 0.86
The HTLV-1 hbz antisense gene indirectly promotes tax expression via down-regulation of p30(II) mRNA. Virology (2010) 0.85